ICSMA-20-254-01: Philips Patient Monitoring Devices (Update C)
CISA advisory · released 2020-09-10
Source record Collected from CISA's CSAF advisory feed
- Distribution label in the document: TLP:WHITE
- Revision 4, 2023-12-14 (final)
CISA's summary
Risk evaluation: Successful exploitation of these vulnerabilities could result in unauthorized access, interrupted monitoring, and collection of access information and/or patient data. To successfully exploit these vulnerabilities, an attacker would need to gain either physical access to surveillance stations and patient monitors or access to the medical device network.
Products, as the advisory lists them
| Vendor | Product | Version |
|---|---|---|
| Philips | Patient Information Center iX (PICiX) | B.02 |
| Philips | Patient Information Center iX (PICiX) | C.02 |
| Philips | Patient Information Center iX (PICiX) | C.03 |
| Philips | PerformanceBridge Focal Point | A.01 |
| Philips | IntelliVue patient monitor MX100 | <=N |
| Philips | IntelliVue patient monitor MX400-MX850 | <=N |
| Philips | IntelliVue patient monitor MP2-MP90 | <=N |
| Philips | IntelliVue X2 | <=N |
| Philips | IntelliVue X3 | <=N |
DeSpy has not checked any unit, hardware revision or firmware.
Vulnerabilities in this advisory
- CVE-2020-16214 · CWE-1236
In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the software saves user-provided information into a comma-separated value (CSV) file, but it does not neutralize or incorrectly neutralizes special elements that could be interpreted as a command when the file is opened by spreadsheet software.
- CVE-2020-16218 · CWE-79
In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the software does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is then used as a webpage and served to other users. Successful exploitation could lead to unauthorized access to patient data via a read-only web application.
- CVE-2020-16222 · CWE-287
In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.
- CVE-2020-16228 · CWE-299
In Patient Information Center iX (PICiX) Versions C.02 and C.03, PerformanceBridge Focal Point Version A.01, IntelliVue patient monitors MX100, MX400-MX550, MX750, MX850, and IntelliVue X3 Versions N and prior, the software does not check or incorrectly checks the revocation status of a certificate, which may cause it to use a compromised certificate.
- CVE-2020-16224 · CWE-130
In Patient Information Center iX (PICiX) Versions C.02, C.03, the software parses a formatted message or structure but does not handle or incorrectly handles a length field that is inconsistent with the actual length of the associated data, causing the application on the surveillance station to restart.
- CVE-2020-16220 · CWE-1286
In Patient Information Center iX (PICiX) Versions C.02, C.03, PerformanceBridge Focal Point Version A.01, the product receives input that is expected to be well-formed (i.e., to comply with a certain syntax) but it does not validate or incorrectly validates that the input complies with the syntax, causing the certificate enrollment service to crash. It does not impact monitoring but prevents new devices from enrolling.
- CVE-2020-16216 · CWE-20
In IntelliVue patient monitors MX100, MX400-550, MX600, MX700, MX750, MX800, MX850, MP2-MP90, and IntelliVue X2 and X3 Versions N and prior, the product receives input or data but does not validate or incorrectly validates that the input has the properties required to process the data safely and correctly, which can induce a denial-of-service condition through a system restart.
- CVE-2020-16212 · CWE-668
In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the product exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource. The application on the surveillance station operates in kiosk mode, which is vulnerable to local breakouts that could allow an attacker with physical access to escape the restricted environment with limited privileges.
Acknowledgments, as the advisory lists them
- Julian Suleder, Nils Emmerich, Birk Kauer, ERNW Research GmbH: reporting these vulnerabilities to the Federal Office for Information Security (BSI), Germany, in the context for the BSI project ManiMed (Manipulation medical devices)
- Dr. Oliver Matula, ERNW Enno: reporting these vulnerabilities to the Federal Office for Information Security (BSI), Germany, in the context for the BSI project ManiMed (Manipulation medical devices)
- Rey, Netzwerke GmbH: reporting these vulnerabilities to the Federal Office for Information Security (BSI), Germany, in the context for the BSI project ManiMed (Manipulation medical devices)
- Federal Office for Information Security (BSI), Germany: reporting these to Philips
The advisory's legal notice
All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.
Sources
DeSpy's copy of this version is dated 2026-09-28.
This product uses the NVD API but is not endorsed or certified by the NVD.
CVE records: Copyright © 1999-2026, The MITRE Corporation. CVE is a trademark and the CVE logo is a registered trademark of The MITRE Corporation.
CVE Usage: MITRE hereby grants you a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable copyright license to reproduce, prepare derivative works of, publicly display, publicly perform, sublicense, and distribute Common Vulnerabilities and Exposures (CVE™). Any copy you make for such purposes is authorized provided that you reproduce MITRE's copyright designation and this license in any such copy.
CISA's Known Exploited Vulnerabilities catalog and CISA Vulnrichment data are CC0 1.0. CISA advisories are shown with the TLP label their document carries. No endorsement by CISA, DHS, NIST or MITRE is stated or implied.